Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment

Aesthetics Clinical Trial

Official title:
An Evaluator-blinded Multi-center Study of Combined Treatment With Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster as Compared to Single Treatment With Either Azzalure/Dysport Alone or Restylane/Emervel Filler Alone

Status Completed

Clinical Trial Summary

The efficacy and safety, as well as subject satisfaction will be evaluated after single treatment with Azzalure/Dysport alone or Restylane/Emervel filler alone followed by repeated combined treatment with Azzalure/Dysport, Restylane/Emervel filler and Restylane Skinbooster. Subjects will be followed for up to 18 months after initial treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Aesthetics

Clinical Trial Details

NCT number	NCT02297516
Study type	Interventional
Source	Galderma R&D
Contact
Status	Completed
Phase	Phase 4
Start date	November 2014
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04505319` - Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit	N/A
Active, not recruiting	`NCT05355454` - Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face	N/A
Completed	`NCT02703740` - Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds	N/A
Recruiting	`NCT05747456` - Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal)	N/A
Withdrawn	`NCT00845078` - Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer	N/A
Completed	`NCT01412190` - Study to Evaluate Restylane Vital Light Using an Injector Device	N/A